MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference

VALENCIA, Calif., Sept. 2, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that it will present at The Morgan Stanley Global Healthcare Conference on Tuesday, September 9, 2014 at 12:55 PM (ET) at the Grand Hyatt Hotel in New York City.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

CONTACT: Company Contact:
         Matthew Pfeffer
         Chief Financial Officer
         (661) 775-5300
         [email protected]

You May Also Be Interested In

• Keurig Dr Pepper Inc. (KDP) Confirms Previously Announced Resignation of CEO Gamgort, Appoints Timothy Cofer New CEO
• Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
• VIA optronics AG (VIAO) to Be Delisted from NYSE